Pulmonx Financial Statements From 2010 to 2025

LUNG Stock  USD 8.68  0.24  2.69%   
Pulmonx Corp financial statements provide useful quarterly and yearly information to potential Pulmonx Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Pulmonx Corp financial statements helps investors assess Pulmonx Corp's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Pulmonx Corp's valuation are summarized below:
Gross Profit
62 M
Profit Margin
(0.67)
Market Capitalization
352.2 M
Enterprise Value Revenue
3.6902
Revenue
83.8 M
There are over one hundred nineteen available trending fundamental ratios for Pulmonx Corp, which can be analyzed over time and compared to other ratios. Active traders should verify all of Pulmonx Corp recent fundamental drivers against the trend between 2010 and 2025 to make sure the company can sustain itself down the road. The current Market Cap is estimated to decrease to about 529 M. Enterprise Value is estimated to decrease to about 482.9 M

Pulmonx Corp Total Revenue

82.93 Million

Check Pulmonx Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pulmonx Corp's main balance sheet or income statement drivers, such as Interest Expense of 3.9 M, Selling General Administrative of 108.4 M or Total Revenue of 82.9 M, as well as many indicators such as Price To Sales Ratio of 7.7, Dividend Yield of 0.0 or PTB Ratio of 3.87. Pulmonx financial statements analysis is a perfect complement when working with Pulmonx Corp Valuation or Volatility modules.
  
Check out the analysis of Pulmonx Corp Correlation against competitors.
For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.

Pulmonx Corp Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets214.7 M204.4 M85.1 M
Slightly volatile
Total Current Liabilities28 M26.6 M9.7 M
Slightly volatile
Accounts Payable1.2 M1.7 M933.2 K
Slightly volatile
Cash58.5 M96.1 M46.3 M
Slightly volatile
Long Term Debt42.4 M40.4 M14.4 M
Slightly volatile
Inventory20.2 M19.3 M7.1 M
Slightly volatile
Total Liabilities61.4 M68.4 M46.9 M
Slightly volatile
Short and Long Term DebtM1.9 M883.7 K
Very volatile
Total Current Assets181.6 M173 M74.2 M
Slightly volatile
Short Term Debt6.3 MM2.5 M
Slightly volatile
Common Stock25 K44.9 K23 K
Slightly volatile
Property Plant Equipment4.1 M6.1 M3.3 M
Slightly volatile
Net Receivables15.7 M15 M5.2 M
Slightly volatile
Other Assets1.091.15715.8 K
Pretty Stable
Other Current Assets4.3 M4.1 M1.6 M
Slightly volatile
Intangible Assets26.5 K27.9 K216.3 K
Very volatile
Short and Long Term Debt Total32.1 M47.6 M32.7 M
Very volatile
Other Current Liabilities11.5 M18.7 M8.8 M
Slightly volatile
Other Liabilities58.1 K84.6 K101 K
Slightly volatile
Property Plant And Equipment NetM8.5 M4.4 M
Slightly volatile
Current Deferred Revenue102.7 K93.6 K129.9 K
Slightly volatile
Non Current Assets Total20 M31.5 M11.9 M
Slightly volatile
Non Currrent Assets Other2.2 M3.6 M1.3 M
Slightly volatile
Cash And Short Term Investments128.8 M134.7 M62.4 M
Slightly volatile
Good Will1.9 M2.1 M2.3 M
Slightly volatile
Common Stock Total Equity32.3 K43.7 K24.8 K
Slightly volatile
Common Stock Shares Outstanding37.2 M43.7 M28.1 M
Slightly volatile
Liabilities And Stockholders Equity172.1 M204.4 M89.7 M
Slightly volatile
Non Current Liabilities Total31 M32.7 M122.9 M
Slightly volatile
Property Plant And Equipment Gross7.3 M14.1 MM
Slightly volatile
Accumulated Other Comprehensive Income1.9 MM1.6 M
Slightly volatile
Capital Stock34.1 K44.9 K25.1 K
Slightly volatile
Net Working Capital134.9 M146.4 M65.2 M
Slightly volatile
Deferred Long Term Liabilities80.4 K84.6 KM
Slightly volatile
Long Term Debt Total658.9 K729.1 K593.4 K
Slightly volatile
Capital Surpluse532.7 M578.1 M483.6 M
Slightly volatile
Non Current Liabilities Other12.2 M19 M21.4 M
Slightly volatile

Pulmonx Corp Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative108.4 M103.3 M34.4 M
Slightly volatile
Research Development21.8 M20.8 M7.3 M
Slightly volatile
Tax Provision339.7 K654.4 K183.9 K
Slightly volatile
Interest Income5.8 M5.5 M1.2 M
Slightly volatile
Depreciation And Amortization1.8 M2.2 MM
Slightly volatile
Other Operating Expenses89.7 M150.2 M63.1 M
Slightly volatile
Reconciled DepreciationM1.9 M699.2 K
Slightly volatile
Selling And Marketing ExpensesM5.5 M2.1 M
Slightly volatile

Pulmonx Corp Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation1.9 M1.8 M550 K
Slightly volatile
Capital Expenditures802.6 K928 K610 K
Slightly volatile
Total Cash From Financing Activities33.3 M24.6 M24.6 M
Slightly volatile
Change To Netincome20.6 M19.6 MM
Slightly volatile
End Period Cash Flow93.5 M96.4 M53.5 M
Slightly volatile
Stock Based Compensation26.7 M25.4 M6.8 M
Slightly volatile
Begin Period Cash Flow93.8 M117.3 M50.2 M
Slightly volatile
Other Cashflows From Financing Activities1.3 M1.3 M11.1 M
Pretty Stable
Other Non Cash Items2.5 M2.5 M1.2 M
Slightly volatile
Dividends Paid18 M19.3 M35.2 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio7.78.1133.5539
Slightly volatile
Days Sales Outstanding47.2662.2860.208
Slightly volatile
Stock Based Compensation To Revenue0.30.290.1068
Slightly volatile
Capex To Depreciation0.570.61.3243
Very volatile
EV To Sales7.037.433.6341
Slightly volatile
Inventory Turnover1.471.231.8321
Slightly volatile
Days Of Inventory On Hand252307232
Slightly volatile
Payables Turnover6.0710.786.892
Slightly volatile
Sales General And Administrative To Revenue1.01.181.1141
Slightly volatile
Average Inventory12.5 M14.1 M15.4 M
Slightly volatile
Research And Ddevelopement To Revenue0.290.30.3106
Slightly volatile
Capex To Revenue0.010.01060.0203
Pretty Stable
Cash Per Share2.582.781.6445
Slightly volatile
Days Payables Outstanding59.7335.0656.7682
Slightly volatile
Income Quality0.950.710.9254
Slightly volatile
Intangibles To Total Assets0.01450.01530.1198
Slightly volatile
Current Ratio6.95.854.7313
Slightly volatile
Receivables Turnover6.946.076.1031
Slightly volatile
Graham Number9.069.5411.7766
Slightly volatile
Capex Per Share0.02930.01910.0244
Slightly volatile
Revenue Per Share0.981.631.1085
Slightly volatile
Interest Debt Per Share1.081.351.3925
Slightly volatile
Debt To Assets0.250.271.353
Slightly volatile
Operating Cycle299369292
Slightly volatile
Days Of Payables Outstanding59.7335.0656.7682
Slightly volatile
Ebt Per Ebit1.171.121.1535
Slightly volatile
Quick Ratio6.355.24.1941
Slightly volatile
Net Income Per E B T0.810.910.9858
Slightly volatile
Cash Ratio5.023.253.123
Slightly volatile
Cash Conversion Cycle256342236
Slightly volatile
Days Of Inventory Outstanding252307232
Slightly volatile
Days Of Sales Outstanding47.2662.2860.208
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.830.921.0068
Slightly volatile
Fixed Asset Turnover14.4810.6233.1751
Slightly volatile
Debt Ratio0.250.271.353
Slightly volatile
Price Sales Ratio7.78.1133.5539
Slightly volatile
Asset Turnover0.540.440.9109
Slightly volatile
Gross Profit Margin0.550.670.6438
Slightly volatile

Pulmonx Corp Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap529 M556.8 M889 M
Very volatile
Enterprise Value482.9 M508.4 M872.3 M
Pretty Stable

Pulmonx Fundamental Market Drivers

Forward Price Earnings28.3286
Cash And Short Term Investments117.1 M

Pulmonx Upcoming Events

28th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Pulmonx Corp Financial Statements

Pulmonx Corp stakeholders use historical fundamental indicators, such as Pulmonx Corp's revenue or net income, to determine how well the company is positioned to perform in the future. Although Pulmonx Corp investors may analyze each financial statement separately, they are all interrelated. For example, changes in Pulmonx Corp's assets and liabilities are reflected in the revenues and expenses on Pulmonx Corp's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Pulmonx Corp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue93.6 K102.7 K
Total Revenue79 M82.9 M
Cost Of Revenue20.6 M21.6 M
Stock Based Compensation To Revenue 0.29  0.30 
Sales General And Administrative To Revenue 1.18  1.00 
Research And Ddevelopement To Revenue 0.30  0.29 
Capex To Revenue 0.01  0.01 
Revenue Per Share 1.63  0.98 
Ebit Per Revenue(1.04)(1.09)

Currently Active Assets on Macroaxis

When determining whether Pulmonx Corp is a strong investment it is important to analyze Pulmonx Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulmonx Corp's future performance. For an informed investment choice regarding Pulmonx Stock, refer to the following important reports:
Check out the analysis of Pulmonx Corp Correlation against competitors.
For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmonx Corp. If investors know Pulmonx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmonx Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.44)
Revenue Per Share
2.142
Quarterly Revenue Growth
0.233
Return On Assets
(0.21)
Return On Equity
(0.55)
The market value of Pulmonx Corp is measured differently than its book value, which is the value of Pulmonx that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmonx Corp's value that differs from its market value or its book value, called intrinsic value, which is Pulmonx Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmonx Corp's market value can be influenced by many factors that don't directly affect Pulmonx Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulmonx Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmonx Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmonx Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.